How Bad Will the Stock Market Get?
In recent trading days, global stock markets have seen massive…
Sell
12
BKYI Quote, Financials, Valuation and Earnings
Last price:
$0.63
Seasonality move
:
-0.89%
Day range:
$0.63 - $0.78
52-week range:
$0.52 - $3.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.20x
P/B ratio:
0.65x
Volume:
156.8K
Avg. volume:
337.4K
1-year change:
-63.55%
Market cap:
$2.5M
Revenue:
$6.9M
EPS (TTM):
-$6.13
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, BIO-key International has 354.75% upside to fair value with a price target of $3.00 per share.
BKYI vs. S&P 500
-
Over the past 5 trading days, BIO-key International has underperformed the S&P 500 by -8.04% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
BIO-key International does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
BIO-key International revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter BIO-key International reported revenues of $2.1M.
Earnings Growth
-
BIO-key International has grown year-over-year earnings for 0 quarters straight. In the most recent quarter BIO-key International reported earnings per share of -$0.39.
Enterprise value:
3.7M
EV / Invested capital:
--
Price / LTM sales:
0.20x
EV / EBIT:
--
EV / Revenue:
0.54x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.27x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$4.3M
Return On Assets:
-89.24%
Net Income Margin (TTM):
-72.53%
Return On Equity:
-662.7%
Return On Invested Capital:
-221.43%
Operating Margin:
-27.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $7M | $7.8M | $6.9M | $1.8M | $1.5M | |
| Gross Profit | $4.6M | $1.4M | $5.6M | -$95.5K | $1.2M | |
| Operating Income | -$8.5M | -$8.8M | -$4.2M | -$2.7M | -$1.4M | |
| EBITDA | -$11.4M | -$7.8M | -$3.8M | -$2.3M | -$1.3M | |
| Diluted EPS | -$22.50 | -$15.86 | -$2.24 | -$4.42 | -$0.53 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $18.9M | $14M | $9M | $2.6M | $1.9M | |
| Total Assets | $22.5M | $17.8M | $11.3M | $4.5M | $8.6M | |
| Current Liabilities | $1.9M | $2M | $5.5M | $3.2M | $4.6M | |
| Total Liabilities | $2.2M | $2.2M | $6M | $3.5M | $4.9M | |
| Total Equity | $20.3M | $15.6M | $5.3M | $1.1M | $3.7M | |
| Total Debt | $232K | -- | $3M | $327.5K | $1.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.2M | -$3.8M | -$2.9M | -$1.5M | -$514.6K | |
| Cash From Investing | -$696.6K | -$1K | -$13K | -$1K | $10K | |
| Cash From Financing | $1.9M | $1.4M | $2.8M | $1.6M | -$833.6K | |
| Free Cash Flow | -$6.3M | -$3.8M | -$2.9M | -$1.5M | -$504.6K | |
BKYI
Sector
Market Cap
$2.5M
$74M
Price % of 52-Week High
17.93%
51.68%
Dividend Yield
0%
0%
Shareholder Yield
--
0.76%
1-Year Price Total Return
-63.55%
-26.35%
Beta (5-Year)
0.493
0.881
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.76
200-day SMA
Sell
Level
$1.23
Bollinger Bands (100)
Sell
Level
0.85 - 1.49
Chaikin Money Flow
Sell
Level
-381.4M
20-day SMA
Sell
Level
$0.97
Relative Strength Index (RSI14)
Sell
Level
27.12
ADX Line
Sell
Level
18.45
Williams %R
Buy
Level
-95.1232
50-day SMA
Sell
Level
$1.12
MACD (12, 26)
Sell
Level
-0.12
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Neutral
Level
809.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-21.387)
Sell
CA Score
(Annual)
Level (-3.5114)
Buy
Beneish M-Score
(Annual)
Level (-3.5213)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (7.1273)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Stock Forecast FAQ
In the current month, BKYI has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BKYI average analyst price target in the past 3 months is $3.00.
-
Where Will BIO-key International Stock Be In 1 Year?
According to analysts, the consensus estimate is that BIO-key International share price will rise to $3.00 per share over the next 12 months.
-
What Do Analysts Say About BIO-key International?
Analysts are divided on their view about BIO-key International share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BIO-key International is a Sell and believe this share price will drop from its current level to $3.00.
-
What Is BIO-key International's Price Target?
The price target for BIO-key International over the next 1-year time period is forecast to be $3.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BKYI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for BIO-key International is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BKYI?
You can purchase shares of BIO-key International via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BIO-key International shares.
-
What Is The BIO-key International Share Price Today?
BIO-key International was last trading at $0.63 per share. This represents the most recent stock quote for BIO-key International. Yesterday, BIO-key International closed at $0.66 per share.
-
How To Buy BIO-key International Stock Online?
In order to purchase BIO-key International stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is JOBY Stock a Buy, Sell or Hold?
Joby Aviation (NYSE:JOBY) got started with the big idea of…
Why Did Tesla Stock Fall So Sharply?
Tesla (TSLA) stock has often gone against the grain. It…
Stock Ideas
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
20
Is AAPL Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 29x
Sell
33
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Sell
24
FNGA alert for Apr 8
MicroSectors FANG+ Index 3X Leveraged ETN [FNGA] is down 1.93% over the past day.
Buy
75
SOXS alert for Apr 8
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 11.22% over the past day.
Buy
82
TECS alert for Apr 8
Direxion Daily Technology Bear 3x Shares [TECS] is up 5.94% over the past day.
